WNT5A expression is up-regulated in lung cancer, ovarian cancer, pancreatic cancer, PCa and gastric cancer, and the overexpression of WNT5A is associated with invasiveness, progression and poor prognosis of these tumors [17, 20–22, 37]. Here, WNT5A is linked to lung carcinoma.